In critically ill patients with COVID-19, IL-6 receptor antagonists reduced mortality vs. control at 180 d. Fuller C, Chagla Z. Ann Intern Med 2023 Apr 4. doi: 10.7326/J23-0020.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fuller C, Chagla Z. In critically ill patients with COVID-19, IL-6 receptor antagonists reduced mortality vs. control at 180 d. Ann Intern Med 2023 Apr 4. doi: 10.7326/J23-0020.
PMID: 37011390